About Valneva SE - ADR (VALN)
Valneva is a biotechnology company. The Company focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva serves customers in France.
- USD5.78
- USD5.78
- USD5.57
- 11.45k
Stock News
3 hours ago
Meta’s stock hits a record high as Mark Zuckerberg goes on an AI hiring spree
MarketWatch
3 hours ago
25-year-old skipped college—now her company brings in more than $1 million a week on Whatnot
CNBC
3 hours ago
QXO turns attention elsewhere as Home Depot nabs GMS - source
Yahoo
5 hours ago
Market lessons from the first half of 2025 — and, stocks that look good going forward
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
